Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Choudhury, Ananta
- Importance and Utility of Vagina as a Route for Drug Delivery System
Abstract Views :288 |
PDF Views:2
Authors
Affiliations
1 Columbia Institute of Pharmacy, Tekari, Raipur, IN
1 Columbia Institute of Pharmacy, Tekari, Raipur, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 4, No 2 (2014), Pagination: 86-92Abstract
The purpose of this review article is to highlight the importance of vaginal drug delivery system. Several studies proven that vagina is an effective route for drug administration intended for local action as well as systemic action. This route offers many advantages due to its large permeation area, permeability to large molecular weight drugs, rich vascularization, avoidance of first pass metabolism and relatively low enzymatic activity. Through this route steroidal compounds, spermicidal agents are already delivered to obtain suitable therapeutics action for prolong period of time with minimal side effects. Recently the vaginal route has been investigated for peptide and protein drug delivery. In this review we focused on different aspects related to vaginal drug delivery systems along with their anatomy physiology and factors affecting drug absorption from the vaginal route.Keywords
Vagina, Intravaginal Route, Peptide and Protein Drug Delivery.References
- Choudhury A., Das S., Kar M., A Review on Novelty and Potentiality of Vaginal Drug Delivery, International Journal of PharmaTech Research, Vol. 3, 2011, P- 1033-1044.
- Chien Y. W., Yu K., Vaginal delivery and absorption of drugs. Encyclopedia of Pharmaceutical Technology. Vol. 16. Marcel Dekker Inc.; 1997: P.153-185.
- Garg S., Vermani K, The scope and potential of vaginal drug delivery. Pharm Sci Technology Today, 2000, p. 359-364.
- N. Dobaria, R. Mashru and N. H. Vadia Vaginal drug delivery systems: A Review of Current Status , East and Central African Journal of Pharmaceutical Sciences Vol. 10 2007, p. 3-13.
- Ashok.V, Kumar R. M., Murali D. and Chatterjee A., A review on vaginal route as a systemic drug delivery, Critical Review in Pharmaceutical Sciences, Vol 1(1), 2012, p. 1-19.
- Vagina, The Free Histology Encyclopedia, Available at: http://www.ihcworld.com/histowiki/doku.php?id=vagina.
- Chein. Y. W.,"Novel Drug Delivery System" 2nd edition, p. 529-584.
- Robinson J. R., X. Absorption Enhancers. In Encyclopedia of Pharmaceutical Technology; J. Swarbrick and J.C. Boylan, Eds, Marcel Dekker, Inc. New York, vol 18, 1999, p. 1-27.
- Howard C. A., Loyd V. A., Jr. Nicholas G. P., Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 8th edition.
- Ansel H. C., Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery, 6th ed. Malvern, P. A. Williams and Wilkins 1985, p. 424.
- Ansel H. C., Allen V., Jr. Nicholas G, Ansel's P., Pharmaceutical Dosage Forms and Drug Delivery Systems. 8th edition.
- Guyot M., Fawaz F. Present and future choices of vaginal drug dosage forms. Classical forms., J. Pharm Belg 1993, p. 393.
- Gad cox shayne',"Pharmaceutical Manufacturing Handbook", Vaginal Drug Delivery, p. 809-857.
- Fusun A., Gazi university, Faculty of Pharmacy, Department of1. Choudhury A., Das S., Kar M., A Review on Novelty and Potentiality of Vaginal Drug Delivery, International Journal of PharmaTech Research, Vol. 3, 2011, P- 1033-1044.
- Ahuja A., Khar R., Ali J. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm., 1997, p. 489–415.
- Patel G. M. and Patel A. P., A novel effervescent bioadhesive vaginal tablet of ketoconazole: formulation and Invitro evaluation, International Journal of PharmTech Research Vol.2, No.1, p. 656-667.
- Bansal K., Pant P., Rao P. R. T., Padhee K, Sathapathy A., Prithipal Singh Kochhar, Development and Evaluation of Dienogest Vaginal Tablet for Treatment of Endometriosis, International Journal of Research in Pharmaceutical and Biomedical Sciences Vol. 2, 2011, p. 728-737.
- EL-Kamel A. S., Sokar M. S., Naggar V. F., Gamal S. S., Bioadhesive controlled release metronidazole vaginal tablets, Acta Pharm. 52 (2002) p. 171–179.
- Bhowmik B. B., Nayak B. S., Rout P. K. and Nayak U. K., formulation Development and Characterization of Metronidazole Microencapsulated Bioadhesive Gel for Vaginal Use, International Journal of PharmTech Research Vol.3, p. 209-219.
- Neves J. D., Bahia M. F., Gels as vaginal drug delivery systems, International Journal of PharmTech Research (2006) p. 1–14.
- Milica S., Vesna S., Valentina M., Development of Formulations for Vaginal gel carrier in the Pharmacy a Regulatory and Quality Aspect, Scientific Journal of the Faculty of Medicine in Niš 2012, 23-30.
- Yellanki S. K., Nerella N. K., Goranti S., Deb K. S., Development of Metronidazole Intravaginal gel for the treatment of bacterial vaginosis: Effect of Mucoadhesive Natural Polymers on the Release of Metronidazole, International Journal of PharmTech Research, Vol.2, No.3, July-Sept 2010, p. 1746-1750.
- Francois M., Snoeckx E., Putteman P., Wouters F., Proost D. E., Delaet J., A Mucoadhesive, Cyclodextrin-based Vaginal Cream Formulation of Itraconazole, January 16, 2003; Published: March 6, 2003, 1-5.
- USP Clindamycin Phosphate Vaginal Cream, for intravaginal use only not for ophthalmic. Dermal or oral use. Revised June 2008, p 1-11.
- Abass H., Kamel R., Abdelbary A., Metronidazole bioadhesive vaginal suppositories: formulation, in vitro and in vivo evaluation, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 4, Issue 1, 2012, p. 344-355.
- European Pharmacopoeia 5.0, Veterinary liquid preparations for cutaneous application, p. 630-631.
- Gertrude-E. C., Hans A. R., Robert P., Eric E., and Roger D. C., Vaginal irritation models: The Current Status of Available Alternative and In Vitro Tests, 2011, p. 317-337.
- Robert P., Eric D., Gertrude-E. C., Hans A. R., Rodger D. C., Current status of available In vitro tests for vaginal irritation assessment, Institute for In vitro Science, Inc. (IIVS), Gaithersburg, MD, USA.
- Ayehunie S., Cannon C., LaRosa K., Pudney J., Anderson J. D. and Klausner M., Development of an in vitro alternative assay method for vaginal irritation. January 2011, p. 130–138.
- Esra B., Zeynep A. S., Sinem Y. K. and Andreas B. S., Strategies to Prolong the Intravaginal Residence Time of Drug Delivery Systems, J Pharmaceutical Science (www.cspsCanada.org) 2009, p. 312 – 336.
- Lee C.H., Anderson M. and Chein Y.W., The characterization of in-vitro spermicidal activity of chelating agent on human sperm, J. Pharm. Sci., 1996, p. 649-54.
- Gynecol O. J.,Van C. J., The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. Pub med 1991 Oct. p. 165.
- Chami F., Chami N., Bennis S., Trouillas J., Remmal A., Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model, Journal of Antimicrobial Chemotherapy (2004), p. 909–914.
- Osmond J. D., Douglas E., Fatih M. U., A Study of the Potential of the Pig as a Model for the Vaginal Irritancy of Benzalkonium Chloride in Comparison to the Nonirritant Microbicide PHI-443 and the Spermicide Vanadocene Dithiocarbamate, drug discovery program, department of reproductive biology, experimental pathology and virology. Paradigm Pharmaceuticals. Vol. 33, No. 4, 2005. p. 464-476.
- Manzer J. D., Akira K. ' Norman F.H. Ho , Jeffrey L. F. and William I. H., Topical vaginal drug delivery in the guinea pig. I. International Journal of PharmaTech Research 24 (1985) p. 209-218.
- Gupta A. K. Introduction to Pharmaceutics I-II CBS publishers and Distributers, 3rd edition, Darya Ganj, New Delhi India.
- Extraction and Evaluation of Some Phytochemcial and Physicochemical Properties of Hibiscus rosasinensis Mucilage
Abstract Views :249 |
PDF Views:0
Authors
Affiliations
1 Columbia Institute of Pharmacy, Village Tekari, Near Vidhan Sabha, Raipur (CG), IN
2 Bengal School of Technology, Sugandha, Delhi Road, Hooghly, (W.B), IN
1 Columbia Institute of Pharmacy, Village Tekari, Near Vidhan Sabha, Raipur (CG), IN
2 Bengal School of Technology, Sugandha, Delhi Road, Hooghly, (W.B), IN
Source
Research Journal of Pharmacognosy and Phytochemistry, Vol 8, No 4 (2016), Pagination: 205-208Abstract
Hibiscus rosasinensis (HR) is a shrub belonging to Malvaceae. The leaves of ethanolic extract of HR exhibited antidiabetic activity. Mucilage is present in leaves of HR. The objective of this research is to extract and evaluate the mucilage of HR. Leaves were collected and slurry was prepared which was precipitated using ethanol. The precipitates were separated and dried. The dried mucilage was subjected to various phytochemical and physicochemical tests. The extracted mucilage shows the presence of carbohydrates, reducing sugar and mucilage whereas glycoside, alkaloids, steroids, flavonoids and tannins was absent. The moisture sorption test reveals that the mucilage can sorbed moisture and has ability of swelling in water as shown by result of swelling index test. Other physicochemical studies indicate that the mucilage has properties to be used as excipient. FTIR spectrum shows the presence of various functional groups and bonds it possesses. It can be concluded that the mucilage can be used to prepare dosage form. However, as it can absorb moisture, the prepared dosage form should be packed suitably to avoid the contact of moisture.Keywords
Efficacy, Safety, Lesser Side Effects, Memory Loss, Osteoporosis, Immune Disorders, Standardization.- Microemulsion:A Versatile Tool for Ocular Drug Delivery
Abstract Views :166 |
PDF Views:0
Authors
Shashikant Chandrakar
1,
Amit Roy
1,
Ananta Choudhury
1,
Suman Saha
1,
Sanjib Bahadur
1,
Pushpa Prasad
1
Affiliations
1 Columbia Institute of Pharmacy, Raipur, (C.G.), 493111, IN
1 Columbia Institute of Pharmacy, Raipur, (C.G.), 493111, IN
Source
Asian Journal of Pharmacy and Technology, Vol 4, No 3 (2014), Pagination: 147-150Abstract
Eye drops are the most acceptable dosage form by ocular route, which as has disadvantage of bioavailability. The anatomical and physiological constrains limited permeability of drug such as drug loss from the ocular surface by lachrymal drainage, blood-ocular barriers. A number of drug delivery system has been developed to improve the bioavailability and to prolong the residence time of drugs on the eye. Such as promising system for ocular drug delivery is a microemulsion. Microemulsions are clear, stable, isotropic mixtures of oil, water and surfactant, frequently in combination with a cosurfactant. This review gives an overview of the potential of microemulsions as delivery vehicles for eye. Both lipophilic and hydrophilic characteristics are present in microemulsions, so that the loaded drugs can diffuse passively as well get significantly partitioned in the variable lipophilic-hydrophilic corneal barrier.- Preparation and Evaluation of Phytocontituent Based Mucoadhesive Antifungal Vaginal Gel
Abstract Views :181 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, Columbia Institute of Pharmacy, Tekari, Raipur, C.G, IN
1 Department of Pharmaceutics, Columbia Institute of Pharmacy, Tekari, Raipur, C.G, IN
Source
Research Journal of Pharmacognosy and Phytochemistry, Vol 8, No 3 (2016), Pagination: 116-120Abstract
The present experimental work has been designed with an aim to develop a phytoconstitute based mucoadhesive antifungal vaginal gel for wide range of fungal infections. This topic of research has been selected addressing the clinical status of the women's health related problems. Around 75% of world women population experience acute episodes of vaginal candidasis at least once during their life time and if not treated properly may prove life threatening. All the formulations were prepared incorporating optimized concentration of curcumin and fluconazole as active constituents. Antifungal activities of Phyto-combination were screened based on In-Vitro antifungal study. Mucoadhesive polymers like Carbopol 940 and HPMC K4M were used to prepared gel base. In-vitro evaluation such as determination of pH, viscosity, spreadability, mucoadhesive study, Drug content, drug release study and In-Vivo study like RVI (rabbit vaginal irritation test) were performed to evaluate the performance of prepared formulations. Based on the result it was concluded that prepared formulations were safe, effective and overall performances were found satisfactory. Among the several preparations, F2 formulations that contain 1:4 ratios of curmumin and fluconazole shows better result.Keywords
Mucoadhesive Gel, Antifungal Vaginal Formulation, Vaginal Drug Delivery, Curcumin as Antifungal, Phytoconstituent Based Formulation, Fluconazole Gel.- Natural Excipient Development:Need and Future
Abstract Views :230 |
PDF Views:1
Authors
Sanjib Bahadur
1,
Amit Roy
1,
Ranabir Chanda
2,
Ananta Choudhury
1,
Sujoy Das
3,
Suman Saha
1,
Shashikant Chandrakar
1,
Pushpa Prasad
1
Affiliations
1 Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), IN
2 Bengal School of Technology, Sugandha, Delhi Road, Hooghly (W.B), IN
3 GRY Institute of Pharmacy, Vidya Vihar, Borawan, Khargone (M.P), IN
1 Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (C.G), IN
2 Bengal School of Technology, Sugandha, Delhi Road, Hooghly (W.B), IN
3 GRY Institute of Pharmacy, Vidya Vihar, Borawan, Khargone (M.P), IN
Source
Asian Journal of Pharmaceutical Research, Vol 4, No 1 (2014), Pagination: 12-15Abstract
The objective of any formulation is to deliver drug to the patient in the definite amount, at the required rate, and maintains the stability of drug over the product's shelf life. To produce a drug formulation in a final dosage form, a number of pharmaceutical ingredients are required. In selecting excipients for pharmaceutical dosage forms and drug products the development pharmacist should be certain about the existing standards and safety parameters of the excipients. This will assure the consistent quality and functioning of the excipient. The selection and testing of non active ingredients or excipient in the design of drug dosage form present to the formulator the challenge of predictive foresight. While the ability to solve problems when they occur is a valuable attribute, the ability to prevent the problem through adequate experimental design is a virtue. The safety and biodegradability issues related to synthetic excipients have necessitates development of new natural excipients. Newer excipients provide the means for simplifying formulation development, and improving overall operational costs while preserving the quality that is expected by the industry. This review focuses on need to develop such newer natural excipients which shall be utilized to develop efficient dosage forms and the economics involved in doing so.- Fabrication and In-Vitro Evaluation of Liposomal Quercetin and its Optimization
Abstract Views :213 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, IN
2 Department of Pharmaceutics, Assam Down Town University, Assam, IN
1 Department of Pharmaceutics, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, IN
2 Department of Pharmaceutics, Assam Down Town University, Assam, IN
Source
Research Journal of Pharmacy and Technology, Vol 11, No 1 (2018), Pagination: 61-64Abstract
This study intended to explore the influence of formulation factors on the physico-chemical properties of quercetin-loaded liposomes and optimize the fabrication environment. Thin film hydration technique was employed to prepare liposome and optimization was done by 32 factorial designs combined with desirability function. Nine preparations were prepared by using altered drug: lipid and soyphosphatidylcholine: cholesterol (SPC: cholesterol) ratios and assessed for entrapment efficacy and vesicle size. The findings were the mean diameter and drug encapsulation efficiency. Results exhibited that SPC concentration and SPC: cholesterol molar ratio had a solid impact on liposome size. Increasing the lipid ratio produced a reduction in size. The degree of quercetin charging depended on the factors evaluated. Increasing SPC concentration and lipid ratio pointed lyboosted quercetin entrapment. However, higher quercetin concentrations had a negative effect on drug entrapment. Based on this, an optimized design was determined, prepared and investigated. The entrapment efficiency and vesicle size were found to be very adjacent with the predicted values. The formulation was found to be globular shape and also shows sustained release pattern. These results backing the fact that 32 full factorial designs with desirability function might be efficiently used in optimization of quercetin loaded liposome. The overall results showed that SPC concentration and lipid ratio were the key features influencing particle size, while entrapment efficiency was affected primarily by quercetin concentration.Keywords
Fabrication, In-Vitro Evaluation, Liposomal Quercetin.References
- Chouhan M, Saha S, Roy A. Curcumin: A review. J Appl Pharm Res 2014; 11:18-28.
- Lakhanpal P, Rai D. Quercetin: A versatile flavonoid. Internet J Med Update 2007;2: 22-37.
- Mulholland PJ, Ferry DR, Anderson D, Hussain SA, Young AM, Cook JE. Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann Oncol 2001; 12:245-8.
- Saha S, Roy A, Bahadur S, Chandrakar S, Choudhury A, Das S. Phytochemicals as adjuvant in neoplasia. Asian J Res Chem 2014; 7:765-70.
- Gao Y, Wanga Y, Mab Y, Yua A, Caia F, Shaoa W, et al. Formulation optimization and in situ absorption in rat intestinal tract of quercetin loaded micro emulsion. Coll Surf B 2009; 71:306-14.
- Ader P, Wessmann A, Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000; 28:1056-67.
- Zhao L, Shi Y, Zou S, Sun M, Li L, Zhai G. Formulation and In Vitro evaluation of quercetin loaded polymeric micelles composed of pluronicP123 and D-a-tocopheryl polyethylene glycol succinate. J Biomed Nanotechnol 2011; 7:358-65.
- Bhalerao SS, Harshal AR. Preparation, Optimization, Characterization, and Stability Studies of Salicylic Acid Liposomes. Drug Develop Indus Pharm 2003; 29:451-67.
- Roy A, Saha S, Bahadur S, Choudhury A. Bioenhancement of Curcumin by Combined Approaches of Adjuvants and Liposomal Fabrication. Asian J of Pharmaceutics Oct-Dec 2016 (Suppl). 10 (4) | S688
- Van Dijk C, Driessen AJ, Recourt K. The uncoupling efficiency and affinity of flavonoids for vesicles. Biochem Pharmacol 2000; 60:1593-600.
- Taira MC, Chiaramoni NS, Pecuch KM, Alonso-Romanowski S. Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery. Drug Deliv 2004; 11:123-8.
- Saha S, Roy A, Bahadur S, Choudhury A. Bioenhamcement of Curcumin by Dual approach. Research J. Pharm. and Tech 2016; 9(8):1059-1063.
- An Outlook for a Novel Approach:Self-Micro Emulsifying Drug Delivery System (SMEDDS)
Abstract Views :175 |
PDF Views:0
Authors
Affiliations
1 Pharmaceutical Sciences, Assam down Town University, Guwahati–781026, IN
1 Pharmaceutical Sciences, Assam down Town University, Guwahati–781026, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 4 (2019), Pagination: 2055-2064Abstract
Self-micro emulsifying drug delivery system (SMEDDS) has been one of the exclusive approaches to improve solubility and increase bioavailability for the poorly aqueous soluble drug. Due to microstructural features of active entity and formulation as a whole, vigorous researches are being carried to explore the significance and possibility of this drug delivery system at present. SMEDDS is an isotropic mixture of oil, surfactant, co-surfactant and water which involves encapsulation of drug into the lipid base and the formulation as a whole have unique ability to form fine o/w emulsion upon gentle agitation. The whole emulsification process requires only little entropy change which is obtained from the peristaltic motion of gut. Due to microstructural features of active entity and formulation as a whole provided by this approach, vigorous researches are being done at present time to interrelate the in vitro results obtained with in vivo responses. Considering the fact that 40% of the newly discovered drugs are lipophilic in nature, it signifies that the study in this approach will continue and more commercial formulation will be made available in near future. This review gives an overview on SMEDDS with sequential demystification thus enabling a greater understanding of their present role in medicine and drug delivery.Keywords
Self-Emulsifying, Drug Delivery System, Novel Approach, Lipophilic Drug.References
- Tang B, Cheng GG, Xu JC. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discovery Today. 2008;13: 606–612
- Dokania S, Joshi AK. Self-micro emulsifying drug delivery system (SMEDDS) – challenges and road ahead. Drug Delivery. 2015;22: 675-690
- Schulman JH and Hoar TP. Transparent Water-in-oil Dispersion: the Oleopathic Hydro-Micelle. Nature. 1943;152: 102-103
- Bardhan S, Kundu K, Chakraborty G, Saha SK, Paul BK. The Schulman Method of Cosurfactant Titration of the Oil/Water Interface (Dilution Method): A Review on a Well-Known Powerful Technique in Interfacial Science for Characterization of Water-in-Oil Microemulsions. Journal of Surfactants and Detergents. 2015; 18: 547-567
- Patel MJ, Patel SS, Patel NM, Patel MM. A Self-micro-emulsifying Drug Delivery System (SMEDDS). International Journal of Pharmaceutical Sciences Review and Research. 2010;4: 29-35
- Savla R, Browne J, Plassat V, Wasan KM, Wasan EK. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Development and Industrial Pharmacy. 2017; 43(11):1743-1758
- Kalepu S, Nekkanti VK. Insoluble drug delivery strategies: review of recent advances and business prospects. ActaPharmaceuticaSinica B. 2015; 5(5):442-453
- Najjar R. Microemulsions - A Brief Introduction. Available from: URL: https://www.intechopen.com/books/microemulsions-an-introduction-to-properties-and-applications/microemulsions-a-brief-introduction
- Deshmukh A, Kulkarni S. Solid self-micro emulsifying drug delivery system of ritonavir. Drug Development and Industrial Pharmacy. 2014; 40: 477-87
- Zhao K, Yuan Y, Wang H, Li P, Bao Z, Li Y. Preparation and evaluation of valsartan by a novel semi-solid self-micro emulsifying delivery system using Gelucire 44/14. Drug Development and Industrial Pharmacy. 2016; 42: 1545-52
- Tung NT, Tran CS, Pham TM, Nguyen HA, Nguyen TL, Chi SC, Nguyen DD, Bui TB. Development of solidified self-micro emulsifying drug delivery systems containing l-tetrahydropalmatine: Design of experiment approach and bioavailability comparison. International Journal of Pharmaceutics. 2018; 537: 9-21
- Savale S, Chalikwar S. Self-Micro Emulsifying Drug Delivery System (SMEDDS): A Review. Asian Journal of Biomaterial Research. 2017; 3: 12-17
- Jing Q, Shen Y, Ren F, Chen J, Jiang Z, Peng B, Leng Y, Dong J. HPLC determination of anetholetrithione and its application to pharmacokinetics in rabbits. Journal of Pharmaceutical and Biomedical Analysis. 2006; 42(5): 613–617
- Singh AK, Chaurasiya A, Singh M, Upadhyay SC, Mukherjee R, Khar RK. Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS Pharm Sci Tech. 2008; 9(2): 628–634
- Yang S, Gursoy RN, Lambert G, Benita S. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharmaceutical Research. 2004; 21(2): 261–270
- Yao J, Lu Y, Zhou JP. Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats. Journal of Pharmacy and Pharmaceutical Sciences. 2008; 11(3): 22–9
- Chen Y, Li G, Wu X, Chen Z, Hang J, Qin B, Chen S, Wang R (2008). "Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biological and Pharmaceutical Bulletin. 2008; 31(1): 118–25
- Lee S, Lee J, Choi YW. Design and evaluation of prostaglandin E1 (PGE1) intraurethral liquid formulation employing self-microemulsifying drug delivery system (SMEDDS) for erectile dysfunction treatment. Biological and Pharmaceutical Bulletin. 2008; 31(4): 668–672
- Wei L, Sun P,Nie S, Pan W. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Development and Industrial Pharmacy. 2005; 31(8): 785–794
- Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. International Journal of Pharmaceutics. 2004; 274 (1): 65–73
- Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. Journal of Pharmacy and Pharmacology. 2006; 58(9): 1183–1191
- Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics. 2006; 63(3): 288–294
- Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Development and Industrial Pharmacy. 2007. 33(12): 1318–1326
- Goddeeris C, Coacci J, Van den MG. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from SMEDDS. European Journal of Pharmaceutics and Biopharmaceutics. 2007; 66(2): 173–181
- Cirri M, Mura P, Mora PC. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. International Journal of Pharmaceutics. 2007; 340(1): 84-91
- Ito Y, Kusawake T, Prasad YV, Sugioka N, Shibata N, Takada K. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies. International Journal of Pharmaceutics. 2006; 317(2): 114–119
- Yi T, Wan J,Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 70(2): 439–444
- Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Development and Industrial Pharmacy. 2000; 26(5): 523–529
- Holm R, Porter CJ, Edwards GA, Müllertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. European Journal of Pharmaceutical Sciences. 2003; 20(1): 91–97
- Subramanian N, Ray S, Ghosal SK, Bhadra R,Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biological and Pharmaceutical Bulletin. 2004; 27(12): 1993–1999.
- Zhou XT, Wang J, Wang Y, Sun JY, Nie SF, Pan WS. Design and in vitro evaluation of self-microemulsifying drug delivery systems for piroxicam. Acta Pharmaceutica Sinica C. 2008; 43(4): 415–420.
- Reiss H. Entropy-induced dispersion of bulk liquids. Journal of colloid and Interface Science. 1975; 53: 61-70
- Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy. 2004; 58: 173–182
- Patel PK, Patel MR, Patel KR. A review on self-micro emulsifying drug delivery systems. Advance Research in Pharmaceticals and Biologicals. 2014; 4: 590-598
- Reddy BK, Karunakar A. Biopharmaceutics Classification System: A Regulatory Approach. Dissolution Technologies, 2011;1:31-35
- Yasir M, Asif M, Kumar A, Agarwal A. Biopharmaceutical Classification system: An Account. International Journal of Pharm Tech Research. 2010; 2: 1681-1690
- Kohli K, Chopra S, Dhar D. Self-emulsifying drug delivery systems: An approach to enhance oral bioavailability. Drug Discovery Today. 2010; 15: 958-965
- Shukla P, Prajapati SK, Sharma UK, Shivhare S, Akhtar A. A Review on Self-micro Emulsifying Drug Delivery System: An Approach to Enhance the Oral Bioavailability of Poorly Water Soluble Drugs. International Research Journal of Pharmacy. 2012; 3: 1-6
- Kyatanwar A., Jadhav K., Kadam V. Self-micro emulsifying drug delivery system (SMEDDS). Journal of Pharmacy Research. 2010; 3: 75-83
- Yang RN, Lambert GG, Benita S. Enhanced oral absorption of paclitaxel in a novel self-micro emulsifying drug delivery system. Biomedicine and Pharmacotherapy. 2004; 58: 173-182
- Kimura M, Shizuki M, Miyoshi K, Sakai T, Hidaka H, Takamura H, Matoba T. Relationship between the molecular structures and emulsification properties of edible oils. Biotechnology Biochemistry. 1994; 58: 1258–61
- Patil RV, Patil KK, Mahajan VR, Dhaka AS. Self-emulsifying therapeutic- a review. International Journal of Pharmaceutical and Biological Archives. 2012; 3: 481-486
- Mittal P, Rana AC, Bala R, Seth N. Lipid-based self-micro emulsifying drug delivery System (SMEDDS) for lipophilic drugs: an acquainted review. International Research Journal of Pharmacy. 2011; 2: 75-80
- Kalamkar P, Pawar K, Baddi H, Thawkar B, Yevale R, Kale M. A Review on Self Micro Emulsifying Drug Delivery System (SMEDDS). International Journal of Pharmacy and Pharmaceutical Research. 2016; 6: 361-373 (2016)
- Pathak A, Jain V, Nagariya AK. Recent Advances in Self Emulsifying Drug Delivery System - A Review. Drug Invention Today. 2010; 2: 123-129
- Deokate UA, Sindhe N, Bhingare U. Novel approaches for development and characterization of SMEDDS: Review. International Journal of Current Pharmaceutical Research. 2013; 5: 5-12
- Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine: Development and optimization. International Journal of Pharmaceutics. 2010; 391: 203-211
- Pimple SS, Yeole SE, Chaudhari PD. Formulation and Evaluation of Self Micro Emulsifying Drug Delivery system for Poorly Water Soluble Drug Risperidone. International Journal of Pharmaceutical Sciences Review and Research. 2013; 23: 155-162
- Laddha P, Suthar V, Bhutani S. Development and Optimization of self-micro emulsifying drug delivery of domperidone. Brazilian Journal of Pharmaceutical Science. 2014; 50: 91-100
- Kim MS, Ha ES, Choo GH and Baek IH. Preparation and in vivo Evaluation of a Dutasteride-Loaded Solid-Supersaturatable Self-Micro Emulsifying Drug Delivery System. International Journal of Molecular Sciences. 2015; 16: 10821-10833 51. Talele SG, Gudsoorkar VR. Novel Approaches for Solidification of SMEDDS. Journal of Pharmaceutical and Bio Sciences. 2016; 4: 22-23
- Wagh MP, Singh PK, Chaudhari BS, Khairnar DA. Solid Self-emulsifying Drug Delivery System: Preparation Techniques and Dosage Forms. International Journal of Biopharmaceutics. 2014;5: 101-108 53. Maurya SD, Arya RKK, Rajpal G, Dhakar RC. Self-micro Emulsifying Drug Delivery System (SMEDDS) - A Review on Physio-chemical and Biopharmaceutical aspects. Journal of Drug Delivery and Therapeutics. 2017; 7(3): 55-65
- Velayutham R, Masilamani K, Sathesh SK, Vuppalapati L. Bioavailability of poorly water-soluble drugs: Self-emulsifying drug delivery systems: a novel approach. International Journal of Pharmaceutical Sciences Review and Research. 2011; 10: 72-77
- Sharma VK, Koka A, Yadav J, Sharma AK, Keservani RK. Self-Micro Emulsifying Drug Delivery Systems: A Strategy to Improve Oral Bioavailability. Ars Pharmaceutica. 2016; 57: 97-109
- Darsika C, Fatima Grace X, Shanmuganathan S. Self-Micro Emulsifying Drug Delivery System – A Capsulization. Journal of Pharmaceutical Sciences and Research. 2016; 8: 121-124
- Jakki R, Syed MA, Kandadi P, Veerabrahma K. Development of a Self-micro Emulsifying Drug Delivery System of Domperidone: in vitro and in vivo characterization. Acta Pharmaceutica. 2013; 63: 241-251
- Parmar B, Patel U, Bhimani B, Sanghavi K, Patel G, Daslaniya D. SMEDDS: A Dominant Dosage Form Which Improves Bioavailability. American Journal of Pharm Tech Research. 2012; 2: 54-72
- Gautam P, Divyesh S. Self-Micro Emulsifying Drug Delivery System to Enhance the Solubility of the Hydrophobic Drugs. Current Trends in Biomedical Engineering and BioSciences. 2018; 13: 1-6
- Kyatanwar AU, Jadhav KR, Kadam VJ. Self-micro Emulsifying drug delivery system (SMEDDS): Review. Journal of Pharmacy Research. 2010; 3: 75-83
- Suryawansi MR, Kondawar MS. Formulation and Evaluation of Solid self-micro emulsifying drug delivery system of Clarithromycin. Journal of Pharmaceutical Science.2014; 5: 27-35
- Shukla JB, Patel SJ. Formulation and Evaluation of Self Micro Emulsifying System of Candesartan Cilexetil. International Journal of Pharmaceutical Sciences. 2010; 2: 143-146
- Bora DK, Borude P, Bhise K. Formulation and Evaluation of Self micro emulsifying drug delivery system of low solubility drug for enhanced solubility and dissolution. Asian Journal of Biomedical and Pharmaceutical Sciences. 2013; 2: 7-14
- Cote S, Gaudel G, Peracchia MT. Self-emulsifying and self-microemulsifying formulations for the oral administration of toxoids. 2005; EP1498143A1
- Jody Firmin Marceline Voorspoels. Self-microemulsifying drug delivery systems of a HIV protease inhibitor. 2007; US 2007/0104740 A1
- Vandana Bharat Patravale, Imran Ahmed Khan. Process and Preparation of Self micro/nano emulsifying system and compositions thereof. 2007; 208589
- Christina Holmberg. Self-emulsifying drug delivery system. 2010; US7815933B2
- L. Asem, S. Jiani, Z. Qiang, W. Xueqing, F. Ming. Preparation of sorafenib self-microemulsifying drug-delivery system for oral administration or intravenous injection and use thereof. 2009; CN101584661B
- Chang-Shan Hsu. Self-micro emulsifying oral pharmaceutical composition of a hydrophilic drug and the preparation method thereof. 2012; EP2425818A1
- Jing Lin. Self-Microemulsifying Dosage forms of low solubility active ingredients such as co-enzyme Q10. 2012; US8252326B2
- Igor Legan, JanezKare, PolonaJurkovic. Self-microemulsifying drug delivery system. 2013; US8592490B2
- Igor Legan, Luka Peternal, Mateja Novak Stagoj, Miha Homer, Tanja Rozman Paterka, UrosKlancar. Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate. 2014; WO2014009434A1
- H. Yesim Karasulu, Sebnem Apaydin, Evren Gundogdu, Ilgin Yildirim Simsir, Ugur Onsel Turk, Ercument Karasulu, Candeger Yilmaz, Tugce Turgay. Self-micro/ nanoemulsifying drug carrying system for oral use of Rosuvastatin. 2015; WO2015/142307Al
- Michael A. Zeligs, Irwin C. Jacobs. Self-emulsifying formulations of DIM related indoles. 2018; US 9918965 B2
- Bapurao Tarate, Rahul Chavan, Arvind K. Bansal. Oral solid self-emulsifying formulations: A Patent review. Recent Patents on Drug Delivery and Formulations. 2014;8:1-18
- Laxmikant T. Gadhe, Sameeran V. Kapadi, Baburao Bachkar, Mayur Gandhi, Swati Tatele, G. N. Chaudhari. Recent Patent review on Self-micro emulsifying drug delivery system. World Journal of Pharmaceutical Research. 2015;4(3):965-979
- Synergistic Antifungal Activity of Bioactive Phytochemical in Combination with Standard Antifungal Drugs
Abstract Views :161 |
PDF Views:0
Authors
Affiliations
1 Assam Down Town University, Panikhaiti, Gandhinagar, Guwahati-26 Assam, IN
2 Columbia Institute of Pharmacy, Tekari, Raipur C.G., IN
1 Assam Down Town University, Panikhaiti, Gandhinagar, Guwahati-26 Assam, IN
2 Columbia Institute of Pharmacy, Tekari, Raipur C.G., IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 5 (2019), Pagination: 2346-2352Abstract
The research work was mainly designed to determine the antifungal activity of curcumin, a potent bioactive phytoconstituent, obtained from Curcuma longa and to explore the possibilities of its use as a combination with commercially available synthetic antifungal drugs for better therapeutic actions. Fluconazole and itraconazole were used as a model drug. Different combinations of curcumin with fluconazole as well as itraconazole was prepared and subjected to an antifungal screening study. The antifungal screening was carried out using Candida albicans fungal strain. The MIC of fluconazole, itraconazole and curcumin was found to be in the range of 32 μg/ml to 64 μg/ml, 8 μg/ml to 32μg/ml and 64 μg/ml to 256 μg/ml respectively. Further, the results of the invitro antifungal study performed based on the comparative zone of inhibition measurement of the prepared combination at a concentration of 10 μg/ml were determined. The result of the study indicates that the presence of curcumin significantly increases the antifungal capacity of both fluconazole and itraconazole. The Fractional inhibitory concentration index was measured, and the data thus obtained, states that the increased antifungal activity may be observed due to synergistic or additive effects. Further, the topical sensitivity of the optimized combinations was determined using rabbit vaginal model and were found to be free from any major sign of sensitivity as per as histopathological study concern.Keywords
FICI, Natural Antifungal, Candida albican, Curcumin, Antifungal Combination.References
- Umme H, Hosakote G S, Vaghela R, Osmani RA and Shrivastava A, Candidiasis: A fungal infection- current challenges and progress in prevention and treatment, Infect. Disord.: Drug Targets, 2015, 15, 42-52
- Choudhury A, Roy A, Bahadur S, and Saha S, Phytoconstituent based mucoadhesive antifungal vaginal formulation: An effective and innovative approach, Biosci. Biotechnol. Res. Commun., 2016, 9(4), 694-701
- Denning D W and Hope WW, Therapy for fungal diseases: Opportunities and priorities, trends in microbiology.(IN PRESS)
- Wagner H, and Merzenich G U, Synergy research: Approaching a new generation of phyto pharmaceuticals. J. Nat. Rem.,2009, 9(2), 121 – 141
- Matlock K, Berlow N, Keller C, and Pal R, Combination therapy design for maximizing sensitivity and minimizing toxicity, BMC Bioinf., 2017, 18(4),17-29.
- Badiee P and Hashemizadeh Z, Opportunistic invasive fungal infections: Diagnosis and clinical management, Indian J Med Res, 2014, 139,195-204.
- Mohapatro SK, Dandapat MC and Padhi NC, Toxicity and sideeffects of combination chemohormonal therapy of advanced breast cancer, J Indian Med Assoc., 1992, 90(2):39-42.
- Chanda S and Rakholiya K, Combination therapy: Synergism between natural plant extracts and antibiotics against infectious diseases. Science against microbial pathogens: communicating current research and technological advances. Formatex, 2011, 520-529
- Doble M, Hemaiswarya S and Kruthiventi A K, Synergism between natural products and antibiotics against infectious diseases, Phytomedicine, 2008, 15, 639–652
- Barbier R, Coppo E, Marchese A, Daglia M, Sánchez Eet al., Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity, Microbiol. Res., 2017, 196, 4468
- Cowan M M, Plant Products as Antimicrobial Agents, Clin. Microbiol. Rev., 1999,12(4), 564–582
- Choudhury A, Verma A, Sinha D, Shau S and Roy A, Development and characterization of topical phyto-formulation for antifungal activity, J. Appl. Pharm. Res.2014, 1(2), 18-21.
- Choudhury A, Roy A, Bahadur S, and Saha S, Preparation and evaluation of plant bioactive phytochemical based bioadhesive antifungal vaginal formulation. Indo Am. J. Pharm. Sci., 2016, 3 (12), 1673-1681
- Septama AW and Pharkphoom P, Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli, Pharm Biol, 2016, 54(4), 686–691
- Pereira A F, Gomes A S G, Curvelo J A R R and Soares MA, Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR phenotype. Med. Mycol., 2012, 50, 26–32.
- Fratinia F, Mancinia S, Turchia B, Frisciaa E, Pistellib Let al., A novel interpretation of the Fractional Inhibitory Concentration Index: The case Origanum vulgare L. and Leptospermum scoparium J. R. Forst essential oils against Staphylococcus aureus strains, Microbiol. Res.2017,195, 11–17.
- Mehta S, Verstraelen H, Peremens K, Villeirs G, and Vermeire S, Vaginal distribution and retention of a multiparticulate drug delivery system assessed by gamma scintigraphy and magnetic resonance imaging. Int. J. Pharm.,2012, 426, 44-53
- Rabindranath P, Chakraborty M, Rabindra D, and Gupta BK. Invitro In-vivo correlation (IVIVC) study of leflunomide loaded microspheres. Int. J. Pharm. Sci.,2009, 1, 165-170.
- D’Cruz O J, Waurzyniak B and Uckun F M, Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein. Toxicol. Pathol.,2004, 32, 212–221
- TehC H, Nazni WA, Nurulhusna A H, Norazah A and Lee H L, Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay, BMC Microbiol., 2017, 17(36), 1-8